One study examined the synergism of these pathologies using 1 month of CIH exposure, and found increased markers of astrocyte activation in the APP/PS1 mouse model, another AD-like cerebral amyloidosis mouse model [34]. This evidence concerns the gene APP and Alzheimer disease.